Drug Discovery · San Francisco, CA · Founded 2000 · Privately Held (backing)
Developer of first-in-class immune-modulators to target diseases of the immune system. AltruBio is based in San Francisco, CA and was founded in 2000. It has raised $337 million across 1 recorded round; the latest was a $225 million Series B in May 2024.
Last price · $/share
—
Implied valuation
—
Total raised
$336.6M
Last round
Later Stage VC (Series B)
May 2024
Cap table — not yet on record
AltruBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AltruBio with a free account
·Watch AltruBio: the Monday email on marks, rounds and moves